Credit Suisse on Reliance Industries | The brokerage believes that revamped Embibe app should position the company as a key player in EdTech.
CLSA on IndusInd Bank | CLSA expects IndusInd Bank to deliver 15 percent RoE by FY23/24 and finds valuations at current levels reasonable. It maintains a Buy call.
Morgan Stanley on Dr Reddy's Laboratories | The brokerage has an Overweight call on Dr Reddy’s with an expectation of earnings upcycle, led by India/EM markets.
UBS on United Breweries | UBS maintains its Neutral stance on UBL with Heineken looking to consolidate its stake.
CLSA on OIL India | CLSA upgrades the stock to Buy as it finds the company the only midcap to offer positive leverage to crude.
CLSA on ZEEL & Sun TV | CLSA has a Buy rating on both ZEEL and Sun TV, but finds ZEEL better placed on growth parameters.Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Over 50 onion farmers detained in Nashik ahead of PM Modi's visit
May 16, 2024 11:14 AM
Why Google CEO is cautiously optimistic about the election year
May 16, 2024 9:51 AM
Mark Mobius reveals how markets will react if NDA wins 400+ Lok Sabha seats
May 15, 2024 8:09 PM